Welcome to our dedicated page for Buda Juice SEC filings (Ticker: BUDA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Buda Juice, Inc. filings document the beverage company's transition to a NYSE American public issuer, including registration-statement prospectus materials, 8-K reports, underwriting agreements and common-stock issuance details from its initial public offering.
The company's regulatory disclosures also cover capital-structure items such as underwriter warrants, over-allotment option exercise, equity incentive plan adoption, shareholder voting matters and governance disclosures tied to its Ultra Fresh™ juice, lemonade and wellness-shot business.
Buda Juice, Inc. executive Karen Dale Lonsdale-Hands, Vice President of Marketing, filed an initial ownership report showing 47,125 shares of restricted common stock held directly. The footnote states these shares were granted via the 2025 Equity Incentive Plan, indicating an equity award rather than open-market trading.
BUDA JUICE, INC. director and Chief Executive Officer Horatio William Lonsdale-Hands filed an initial Form 3 showing his beneficial ownership in the company. He reports direct ownership of 2,249,417 shares of common stock, including 412,366 shares of restricted common stock granted under the 2025 Equity Incentive Plan.
BUDA JUICE, INC. director Short Donald Wilson filed an initial ownership report showing beneficial ownership of 76,789 shares of restricted common stock. These shares are held directly and were granted under the company’s 2025 Equity Incentive Plan, with no separate buy or sell transaction reported.
Buda Juice, Inc. Chief Financial Officer Clint Lee Bowers reported his initial ownership in the company’s common stock. The filing shows he directly holds 113,100 shares of restricted common stock, granted under the company’s 2025 Equity Incentive Plan.
BUDA JUICE, INC. director and more than 10% owner Herr Bryan Clements has reported his initial holdings on a Form 3. As of January 9, 2026, he directly holds 2,644,466 shares of common stock, including 188,500 shares of restricted common stock granted under the 2025 Equity Incentive Plan.
BUDA JUICE, INC. director and more than ten percent owner Bernard Lucien Nussbaumer filed an initial ownership report showing he directly holds 2,904,860 shares of the company’s common stock as of 2026-01-09. This Form 3 does not reflect any new buy or sell transaction, only existing holdings.
Buda Juice, Inc. reported that Public Ventures, LLC (doing business as MDB Capital), the underwriter of its initial public offering, fully exercised its over-allotment option on January 21, 2026. This option exercise led the company to sell an additional 399,999 shares of common stock.
As a result, Buda Juice received additional gross proceeds of $2,999,992.50 before underwriting discounts, commissions, and offering expenses. This increases the cash raised from its IPO, providing more capital for the company following its recent market debut.
Grow Funds LLC filed a Schedule 13G showing it beneficially owns 945,676 shares of Buda Juice, Inc. common stock, representing about 7.23% of the outstanding class.
Grow Funds reports sole power to vote these shares, with no shared voting or dispositive power, and certifies that the position is held without the purpose or effect of changing or influencing control of the company.
Buda Juice, Inc. reported that it entered into an underwriting agreement for its initial public offering of 2,666,667 common shares at $7.50 per share, for gross proceeds of $20 million before fees and expenses. The underwriters received warrants to purchase 266,667 shares at an exercise price of $9.375 per share, exercisable from July 7, 2026 until January 7, 2031.
The company also adopted the Buda Juice, Inc. 2025 Equity Incentive Plan to grant equity- and cash-based awards to employees, directors, and consultants. Buda Juice issued press releases announcing the IPO pricing and the start of trading of its common stock on the NYSE American exchange.